Disclosure of interest: Ismail Ismail: nothing to disclose, Abdel Douiri: nothing to disclose, Yanzhong Wang: nothing to disclose, Charles Wolfe: nothing to disclose, Ajay Bhalla: nothing to disclose, Eva Emmett: nothing to disclose, Matthew DL OConnell: nothing to disclose, Iain Marshall: nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2483 - ESOC25-657 RELATIONSHIP BETWEEN LIPOPROTEIN(a) LEVELS AND INTRACRANIAL STENOSIS: INSIGHTS FROM A SINGLE CENTER RETROSPECTIVE STUDY Matteo Paolucci 1 , Giacomo Urbinati 1 , Mauro Gentile 1 , Stefano Forlivesi 1 , Giorgia Arnone 1 , Mario Sebastiani 1 , Andrea Zini 1 1 IRCCS Istituto delle Scienze Neurologiche di Bologna, Department of Neurology and Stroke Centre, Maggiore Hospital, Bologna, Italy Background and Aims: Lipoprotein(a) [Lp(a)] has emerged as an independent cardiovascular risk factor, with its role in intracranial atherosclerotic stenosis (ICAS) under increasing scrutiny
He is also the Associate Vice President for Translational Integration and the Program Leader for the Genetics and Gene Regulation in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center
Subcellular localisation of PlexinB1, Sema4D and Ran PlexinB1 activation influences the nuclear/cytoplasmic transport of nuclear receptors [33, 34], which is regulated by the RanGTP/GDP cycle [5, 6]
But they can also become a double-edged sword for your health
Those experiencing fatigue, brain fog, or stress
